A New Anti-VEGF Drug?

Recent human clinical and pre-clinical research on the benefits of Integrin Peptide Therapy show positive results in blocking VEGF production at its source, thus inhibiting bleeding and fluid leakage in the eye.

 

SEE FULL STORY

If you found this article interesting, you can get updates in your email inbox any time similar articles are posted. The subscription options you will be presented with are based on your interest in this article. Just click here to sign up for a free membership and get started!

Comments

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

More information about formatting options

By submitting this form, you accept the Mollom privacy policy.